The progression of inorganic nanoparticles and natural products for inflammatory bowel disease

被引:23
|
作者
Li, Qingrong [1 ]
Lin, Liting [2 ]
Zhang, Cong [3 ]
Zhang, Hengguo [4 ]
Ma, Yan [3 ]
Qian, Haisheng [3 ]
Chen, Xu-Lin [5 ]
Wang, Xianwen [3 ]
机构
[1] Anhui Med Univ, Sch Basic Med Sci, Dept Pharmacol, Hefei 230032, Peoples R China
[2] Anhui Med Univ, Anhui Prov Inst Translat Med, Res & Engn Ctr Biomed Mat, Sch Biomed Engn, Hefei 230032, Peoples R China
[3] Univ Sci & Technol China, Affiliated Hosp USTC 1, Div Gastroenterol, Div Life Sci & Med, Hefei 230026, Anhui, Peoples R China
[4] Anhui Med Univ, Coll & Hosp Stomatol, Key Lab Oral Dis Res Anhui Prov, Hefei 230032, Peoples R China
[5] Anhui Med Univ, Affiliated Hosp 1, Dept Burns, Hefei 230022, Peoples R China
关键词
Inflammatory bowel disease; Inorganic nanoparticles; Natural product nanomaterials; ROS/RNS; M1; macrophages; TNBS-INDUCED COLITIS; NITRIC-OXIDE; ULCERATIVE-COLITIS; MACROPHAGE POLARIZATION; COLORECTAL-CANCER; SIGNALING PATHWAY; REACTIVE OXYGEN; SELENIUM; CURCUMIN; BAICALIN;
D O I
10.1186/s12951-023-02246-x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
There is a growing body of evidence indicating a close association between inflammatory bowel disease (IBD) and disrupted intestinal homeostasis. Excessive production of reactive oxygen species (ROS) and reactive nitrogen species (RNS), along with an increase in M1 proinflammatory macrophage infiltration during the activation of intestinal inflammation, plays a pivotal role in disrupting intestinal homeostasis in IBD. The overabundance of ROS/RNS can cause intestinal tissue damage and the disruption of crucial gut proteins, which ultimately compromises the integrity of the intestinal barrier. The proliferation of M1 macrophages contributes to an exaggerated immune response, further compromising the intestinal immune barrier. Currently, intestinal nanomaterials have gained widespread attention in the context of IBD due to their notable characteristics, including the ability to specifically target regions of interest, clear excess ROS/RNS, and mimic biological enzymes. In this review, we initially elucidated the gut microenvironment in IBD. Subsequently, we delineate therapeutic strategies involving two distinct types of nanomedicine, namely inorganic nanoparticles and natural product nanomaterials. Finally, we present a comprehensive overview of the promising prospects associated with the application of nanomedicine in future clinical settings for the treatment of IBD (graphic abstract).Graphical AbstractDifferent classes of nanomedicine are used to treat IBD. This review primarily elucidates the current etiology of inflammatory bowel disease and explores two prominent nanomaterial-based therapeutic approaches. First, it aims to eliminate excessive reactive oxygen species and reactive nitrogen species. Second, they focus on modulating the polarization of inflammatory macrophages and reducing the proportion of pro-inflammatory macrophages. Additionally, this article delves into the treatment of inflammatory bowel disease using inorganic metal nanomaterials and natural product nanomaterials
引用
收藏
页数:28
相关论文
共 50 条
  • [21] Treatment Effects of Natural Products on Inflammatory Bowel Disease In Vivo and Their Mechanisms: Based on Animal Experiments
    Zhou, Yaxi
    Wang, Diandian
    Yan, Wenjie
    NUTRIENTS, 2023, 15 (04)
  • [22] Natural products targeting Nrf2/ARE signaling pathway in the treatment of inflammatory bowel disease
    Li, Botong
    Wang, Yixuan
    Jiang, Xiaolin
    Du, Hongwei
    Shi, Yan
    Xiu, Minghui
    Liu, Yongqi
    He, Jianzheng
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 164
  • [23] Nanoparticles Derived from the Natural Antioxidant Rosmarinic Acid Ameliorate Acute Inflammatory Bowel Disease
    Chung, Chan Ho
    Jung, Wonsik
    Keum, Hyeongseop
    Kim, Tae Woo
    Jon, Sangyong
    ACS NANO, 2020, 14 (06) : 6887 - 6896
  • [24] Anti-inflammatory natural products modulate interleukins and their related signaling markers in inflammatory bowel disease: A systematic review
    Gandhi, Gopalsamy Rajiv
    Mohana, Thiruchenduran
    Athesh, Kumaraswamy
    Hillary, Varghese Edwin
    Vasconcelos, Alan Bruno Silva
    Franca, Mariana Nobre Farias de
    Montalvao, Monalisa Martins
    Ceasar, Stanislaus Antony
    Jothi, Gnanasekaran
    Sridharan, Gurunagarajan
    Gurgel, Ricardo Queiroz
    Xu, Baojun
    JOURNAL OF PHARMACEUTICAL ANALYSIS, 2023, 13 (12) : 1408 - 1428
  • [25] Editorial: natural history of irritable bowel syndrome in inflammatory bowel disease
    Shin, Andrea
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (08) : 1300 - 1301
  • [26] Redox-active nanoparticles for inflammatory bowel disease
    Ren, Qinjuan
    Sun, Si
    Zhang, Xiao-Dong
    NANO RESEARCH, 2021, 14 (08) : 2535 - 2557
  • [27] POLYMERIC NANOPARTICLES FOR THE SELECTIVE THERAPY OF INFLAMMATORY BOWEL DISEASE
    Wachsmann, Philip
    Lamprecht, Alf
    NANOMEDICINE: CANCER, DIABETES, AND CARDIOVASCULAR, CENTRAL NERVOUS SYSTEM, PULMONARY AND INFLAMMATORY DISEASES, 2012, 508 : 377 - +
  • [28] Redox-active nanoparticles for inflammatory bowel disease
    Qinjuan Ren
    Si Sun
    Xiao-Dong Zhang
    Nano Research, 2021, 14 : 2535 - 2557
  • [29] Using Drosophila melanogaster as a suitable platform for drug discovery from natural products in inflammatory bowel disease
    Xiu, Minghui
    Wang, Yixuan
    Yang, Dan
    Zhang, Xueyan
    Dai, Yuting
    Liu, Yongqi
    Lin, Xingyao
    Li, Botong
    He, Jianzheng
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [30] Evaluations and Mechanistic Interrogation of Natural Products Isolated From Paeonia suffruticosa for the Treatment of Inflammatory Bowel Disease
    Wu, Kun-Chang
    Lee, Der-Yen
    Hsu, Jeh-Ting
    Cheng, Chi-Fang
    Lan, Joung-Liang
    Chiu, Shao-Chih
    Cho, Der-Yang
    Hsu, Jye-Lin
    FRONTIERS IN PHARMACOLOGY, 2021, 12